Snapshot
- Tau Ventures invested in Blueprint Health’s Series A due to impressive traction and rapid growth.
- Blueprint Health’s unique approach enables continuous tracking of patient progress, accelerating recovery rates.
- The dedicated and committed team at Blueprint Health, led by Danny Fried, was a key attraction.
- Blueprint’s method effectively doubles the recovery rate for mental health patients in the U.S.
Overview
Amit from Tau Ventures, an early-stage VC firm based in Silicon Valley, discusses their recent investment in the $9 million Series A round of Blueprint Health, a leading mental health company. With over 180,000 patients and 4,500 clinicians, Blueprint Health stands out in the mental health care landscape.
Three primary reasons motivated Tau Ventures’ investment. First, Blueprint’s impressive traction prior to Series A was noteworthy. Their rapid growth demonstrated a strong market presence and successful operations.
Second, Blueprint’s innovative approach extends beyond merely connecting clinicians with patients. It enables continuous tracking of patient progress, considering factors like symptoms, sleep, exercise, and treatment goals. By translating session learnings into weekly practices and providing timely resources, patients can recover almost twice as quickly as conventional methods.
Finally, the committed and dedicated team at Blueprint, led by Danny Fried, won Tau Ventures’ admiration. Their strong commitment to improving mental health care reinforced the investment decision. With Blueprint effectively doubling the recovery rate for mental health patients in the U.S., this partnership marks a promising step towards improved mental health outcomes.
